Future directions in preclinical and translational cancer neuroscience research.


Journal

Nature cancer
ISSN: 2662-1347
Titre abrégé: Nat Cancer
Pays: England
ID NLM: 101761119

Informations de publication

Date de publication:
11 2021
Historique:
entrez: 30 7 2021
pubmed: 31 7 2021
medline: 31 7 2021
Statut: ppublish

Résumé

Recent advances in cancer neuroscience necessitate the systematic analysis of neural influences in cancer as potential therapeutic targets in oncology. Here, we outline recommendations for future preclinical and translational research in this field.

Identifiants

pubmed: 34327335
doi: 10.1038/s43018-020-00146-9
pmc: PMC8315010
mid: NIHMS1644027
pii: 10.1038/s43018-020-00146-9
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Pagination

1027-1031

Subventions

Organisme : NIDDK NIH HHS
ID : K01 DK120737
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA177857
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK056638
Pays : United States

Références

Zahalka, A. H. & Frenette, P. S. Nat. Rev. Cancer 20, 143–157 (2020).
doi: 10.1038/s41568-019-0237-2
Arranz, L. et al. Nature 512, 78–81 (2014).
doi: 10.1038/nature13383
Ceyhan, G. O. et al. Gastroenterology 136, 177–186.e1 (2009).
doi: 10.1053/j.gastro.2008.09.029
Amit, M., Na’ara, S. & Gil, Z. Nat. Rev. Cancer 16, 399–408 (2016).
doi: 10.1038/nrc.2016.38
Demir, I. E., Friess, H. & Ceyhan, G. O. Nat. Rev. Gastroenterol. Hepatol. 12, 649–659 (2015).
doi: 10.1038/nrgastro.2015.166
Saloman, J. L., Cohen, J. A. & Kaplan, D. H. Curr. Opin. Neurobiol. 62, 60–67 (2020).
doi: 10.1016/j.conb.2019.11.021
Kamiya, A. et al. Nat. Neurosci. 22, 1289–1305 (2019).
doi: 10.1038/s41593-019-0430-3
Mantyh, P. W. Nat. Rev. Neurosci. 7, 797–809 (2006).
doi: 10.1038/nrn1914
Pastuła, A. et al. Stem Cells Int. 2016, 3710836 (2016).
doi: 10.1155/2016/3710836
Faber, C.L., Matsen, M.E., Meek, T.H., Krull, J.E. & Morton, G.J. J. Vis. Exp. (2020).
Smith-Edwards, K. M. et al. EGastroenterology 157, 522–536.e2 (2019).
doi: 10.1053/j.gastro.2019.04.034
Giladi, A. et al. Nat. Biotechnol. 38, 629–637 (2020).
doi: 10.1038/s41587-020-0442-2
Deborde, S. et al. J. Clin. Invest. 126, 1538–1554 (2016).
doi: 10.1172/JCI82658
Burma, N. E., Leduc-Pessah, H., Fan, C. Y. & Trang, T. J. Neurosci. Res. 95, 1242–1256 (2017).
doi: 10.1002/jnr.23768
Bailey, J. J., Schirrmacher, R., Farrell, K. & Bernard-Gauthier, V. Expert Opin. Ther. Pat. 27, 831–849 (2017).
doi: 10.1080/13543776.2017.1297797

Auteurs

Ihsan Ekin Demir (IE)

Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany. ekin.demir@tum.de.
Department of General Surgery, HPB-Unit, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey. ekin.demir@tum.de.
German Cancer Consortium, Partner Site Munich, Munich, Germany. ekin.demir@tum.de.
CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany. ekin.demir@tum.de.

Carmen Mota Reyes (C)

Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
German Cancer Consortium, Partner Site Munich, Munich, Germany.
CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Wasfi Alrawashdeh (W)

Department of HPB and Transplant Surgery, The Freeman Hospital, Newcastle upon Tyne, UK.

Güralp O Ceyhan (GO)

Department of General Surgery, HPB-Unit, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.

Sylvie Deborde (S)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Helmut Friess (H)

Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
German Cancer Consortium, Partner Site Munich, Munich, Germany.
CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Kıvanç Görgülü (K)

Comprehensive Cancer Center Munich, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Rouzanna Istvanffy (R)

Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
German Cancer Consortium, Partner Site Munich, Munich, Germany.
CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

David Jungwirth (D)

Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
German Cancer Consortium, Partner Site Munich, Munich, Germany.
CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Rohini Kuner (R)

Department of Molecular Pharmacology, Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.

Maria Maryanovich (M)

Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY, USA.
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA.

Shorook Na'ara (S)

Department of Otolaryngology, Head and Neck Surgery, and the Laboratory for Applied Cancer Research, Rappaport Institute of Medicine and Research, The Technion, Israel Institute of Technology, Haifa, Israel.
Head and Neck Center, Rambam Healthcare Campus, Haifa, Israel.

Simon Renders (S)

Division of Stem Cells and Cancer, German Cancer Research Center and DKFZ-ZMBH Alliance, Heidelberg, Germany.
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.

Jami L Saloman (JL)

Department of Medicine, Division of Gastroenterology, Hepatology, & Nutrition, Center for Neuroscience at the University of Pittsburgh, Pittsburgh Center for Pain Research and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Nicole N Scheff (NN)

Hillman Cancer Center and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Hendrik Steenfadt (H)

Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
German Cancer Consortium, Partner Site Munich, Munich, Germany.
CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Pavel Stupakov (P)

Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
German Cancer Consortium, Partner Site Munich, Munich, Germany.
CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Vera Thiel (V)

Division of Stem Cells and Cancer, German Cancer Research Center and DKFZ-ZMBH Alliance, Heidelberg, Germany.
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.

Divij Verma (D)

Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY, USA.
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA.

Bengi Su Yilmaz (BS)

Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
German Cancer Consortium, Partner Site Munich, Munich, Germany.
CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Ruth A White (RA)

Division of Hematology and Oncology, Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY, USA.

Timothy C Wang (TC)

Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY, USA.

Richard J Wong (RJ)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Paul S Frenette (PS)

Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY, USA.
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.

Ziv Gil (Z)

Department of Otolaryngology, Head and Neck Surgery, and the Laboratory for Applied Cancer Research, Rappaport Institute of Medicine and Research, The Technion, Israel Institute of Technology, Haifa, Israel.
Head and Neck Center, Rambam Healthcare Campus, Haifa, Israel.

Brian M Davis (BM)

Center for Neuroscience at the University of Pittsburgh, Pittsburgh Center for Pain Research and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH